Simply Wall St.
How Recent Analyst Moves Are Rewriting the Story for Grupo Supervielle
📊
AI Sentiment
Positive
6/10
- Home
- SUPV
as of 12-05-2025 4:00pm EST
$11.01
$0.45
-3.93%
Grupo Supervielle SA offers financial products & services. The company's segments include Personal and Business Banking, Corporate Banking, Bank Treasury, Consumer Finance, Insurance, and Asset Management and other services. The company provides services to individuals, small businesses, middle-market companies, and large corporates in Argentina. The company also offers mutual fund services.
Chart Type:
Time Range:
| Founded: | 1887 | Country: | Argentina |
| Employees: | N/A | City: | N/A |
| Market Cap: | 450.9M | IPO Year: | 2016 |
| Target Price: | $14.67 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Annual | |
| EPS: | -0.03 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.54 - $19.75 | Next Earning Date: | 11-25-2025 |
| Revenue: | $467,987,272 | Revenue Growth: | -40.22% |
| Revenue Growth (this year): | 20.63% | Revenue Growth (next year): | 22.47% |
AI-Powered SUPV Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 69.59%
69.59%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Grupo Supervielle S.A. each Representing five Class B shares News
SUPV Breaking Stock News: Dive into SUPV Ticker-Specific Updates for Smart Investing
Compare SUPV vs Leading Stocks
See how SUPV stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SUPV Grupo Supervielle S.A. each Representing five Class B shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.